BGM Group Ltd. balance sheet
At the end of fiscal 2025, BGM Group Ltd. had total assets of $434m, total liabilities of $41.9m and shareholders' equity of $391m. It held $9.8m in cash against $0 of debt.
Balance sheet
| Fiscal year | 2018Sept 2018 | 2019Sept 2019 | 2020Sept 2020 | 2021Sept 2021 | 2022Sept 2022 | 2023Sept 2023 | 2024Sept 2024 | 2025Sept 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 6 | 5 | 12 | 10 | 14 | 7 | 10 | 10 |
| Receivables | — | 1 | 1 | 2 | 1 | 2 | 2 | 4 |
| Inventory | — | 13 | 12 | 12 | 9 | 5 | 5 | 20 |
| Total current assets | — | 25 | 38 | 40 | 30 | 35 | 30 | 52 |
| Goodwill | — | — | — | — | — | — | — | 351 |
| Total assets | — | 35 | 48 | 75 | 65 | 51 | 53 | 434 |
| Accounts payable | — | 4 | 4 | 7 | 5 | 4 | 4 | 7 |
| Deferred revenue (current) | — | 2 | 4 | 2 | 1 | 1 | 0 | 3 |
| Total current liabilities | — | 12 | 18 | 18 | 9 | 7 | 9 | 42 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | — | 13 | 19 | 19 | 10 | 7 | 9 | 42 |
| Shareholders' equity | 18 | 20 | 26 | 55 | 53 | 43 | 43 | 391 |
| Non-controlling interests and other (assets − liabilities − equity) | — | 3 | 3 | 2 | 2 | 2 | 1 | — |
| Shares outstanding | — | 90m | 90m | 107m | 108m | 108m | 108m | — |
Compare with peers
- IM Cannabis Corp. balance sheet
- Cumberland Pharmaceuticals Inc balance sheet
- Sunshine Biopharma Inc. balance sheet
- Scilex Holding Co balance sheet
- Biofrontera Inc. balance sheet
Head to head: BGM vs IMCCBGM vs CPIXBGM vs SBFM
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies